Skip to content

HALSTED HAMPTON: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

HALSTED HAMPTON

BE 0762.817.106
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2023 against 2024filed annual accounts (NBB)
Net result for the year
-€160,130
2023 · -€165,109+€4,979
Equity
€187,939
2023 · €348,069-€160,130
Cash
€4
2023 · €15,382-€15,378
Balance sheet total
€325,786
2023 · €638,583-€312,797

Largest movements

2023 to 2024
Assets
  • Receivables within one year -€317,517

    down €317,517 (-54.7%), from €580,018 to €262,501

    of which Other amounts receivable: -€314,943

  • Receivables after one year +€47,520

    new in 2024: €47,520

  • Stocks and contracts -€40,193

    down €40,193 (-100.0%), from €40,193 to €0

  • Cash -€15,378

    down €15,378 (-100.0%), from €15,382 to €4

    mainly Net result for the year (-€160,130) and Short-term financial debts (-€76,842)

  • Tangible fixed assets +€7,461

    up €7,461 (+617.3%), from €1,209 to €8,670

    of which Plant, machinery and equipment: +€6,558

Equity and liabilities
  • Profit (loss) carried forward -€160,130

    down €160,130 (-21.7%), from -€736,931 to -€897,061

  • Short-term financial debts -€76,842

    down €76,842 (-97.8%), from €78,585 to €1,744

    of which Other loans: -€76,842

  • Other debts -€56,934

    down €56,934 (-42.9%), from €132,706 to €75,771

  • Trade debts -€23,753

    down €23,753 (-44.2%), from €53,793 to €30,039

Income statement
  • Gross operating margin +€59,549

    up €59,549 (+34.2%), from -€174,192 to -€114,643

  • Write-downs +€57,690

    up €57,690, from -€57,690 to €0

  • Staff costs +€18,699

    up €18,699 (+113.7%), from €16,452 to €35,151

  • Financial charges -€18,230

    down €18,230 (-72.1%), from €25,271 to €7,041

  • Other operating charges -€4,264

    down €4,264 (-64.9%), from €6,575 to €2,311

From the 2023 result to the 2024 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2023 -€165,109
Gross operating margin +€59,549
Staff costs -€18,699
Depreciation -€709
Write-downs -€57,690
Other operating charges +€4,264
Financial income +€34
Financial charges +€18,230
Result 2024 -€160,130

Cash bridge derived

cash 2023 to 2024

Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€76,541
Investment -€15,077
Financing -€76,842
Cash 2023 €15,382
Net result for the year -€160,130
Depreciation +€1,016
Receivables after one year -€47,520
Stocks and contracts +€40,193
Receivables within one year +€317,517
Deferred charges and accrued income +€1,290
Trade debts -€23,753
Tax, wage and social debts +€4,862
Other debts -€56,934
Investment in fixed assets (net) -€15,077
Short-term financial debts -€76,842
Cash 2024 €4
Every line side by side 45 lines
Line Code 2023 2024 Change %
Total assets 20/58 €638,583 €325,786 -€312,797 -49.0%
Fixed assets 21/28 €1,209 €15,270 +€14,061 +1163.3%
Tangible fixed assets 22/27 €1,209 €8,670 +€7,461 +617.3%
Plant, machinery and equipment 23 - €6,558 +€6,558
Furniture and vehicles 24 €1,209 €2,112 +€904 +74.8%
Financial fixed assets 28 - €6,600 +€6,600
Current assets 29/58 €637,374 €310,516 -€326,858 -51.3%
Amounts receivable after more than one year 29 - €47,520 +€47,520
Other amounts receivable 291 - €47,520 +€47,520
Stocks and contracts in progress 3 €40,193 €0 -€40,193 -100.0%
Stocks 30/36 €40,193 €0 -€40,193 -100.0%
Amounts receivable within one year 40/41 €580,018 €262,501 -€317,517 -54.7%
Trade receivables 40 €25,500 €22,925 -€2,575 -10.1%
Other amounts receivable 41 €554,518 €239,575 -€314,943 -56.8%
Cash at bank and in hand 54/58 €15,382 €4 -€15,378 -100.0%
Deferred charges and accrued income 490/1 €1,782 €492 -€1,290 -72.4%
Total equity and liabilities 10/49 €638,583 €325,786 -€312,797 -49.0%
Equity 10/15 €348,069 €187,939 -€160,130 -46.0%
Contributions 10/11 €1,085,000 €1,085,000 = 0.0%
Profit (loss) carried forward 14 -€736,931 -€897,061 -€160,130 -21.7%
Amounts payable 17/49 €290,514 €137,846 -€152,667 -52.6%
Amounts payable within one year 42/48 €290,514 €137,846 -€152,667 -52.6%
Financial debts 43 €78,585 €1,744 -€76,842 -97.8%
Credit institutions 430/8 €0 - =
Other loans 439 €78,585 €1,744 -€76,842 -97.8%
Trade debts 44 €53,793 €30,039 -€23,753 -44.2%
Suppliers 440/4 €53,793 €30,039 -€23,753 -44.2%
Advances received on contracts in progress 46 €20,000 €20,000 = 0.0%
Taxes, remuneration and social security 45 €5,430 €10,292 +€4,862 +89.5%
Taxes 450/3 €24 €0 -€24 -100.0%
Remuneration and social security 454/9 €5,406 €10,292 +€4,886 +90.4%
Other amounts payable 47/48 €132,706 €75,771 -€56,934 -42.9%
Remuneration, social security and pensions 62 €16,452 €35,151 +€18,699 +113.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €307 €1,016 +€709 +230.5%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 -€57,690 €0 +€57,690
Other operating charges 640/8 €6,575 €2,311 -€4,264 -64.9%
Gross operating margin 9900 -€174,192 -€114,643 +€59,549 +34.2%
Operating profit (loss) 9901 -€139,837 -€153,122 -€13,285 -9.5%
Financial income 75/76B €0 €34 +€34
Recurring financial income 75 €0 €34 +€34
Financial charges 65/66B €25,271 €7,041 -€18,230 -72.1%
Recurring financial charges 65 €25,271 €7,041 -€18,230 -72.1%
Profit (loss) for the period before taxes 9903 -€165,109 -€160,130 +€4,979 +3.0%
Profit (loss) for the period 9904 -€165,109 -€160,130 +€4,979 +3.0%
Profit (loss) for the period to be appropriated 9905 -€165,109 -€160,130 +€4,979 +3.0%

Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 12 October 2026 via checked.be.